Health Experts Raise Alarm Call For Strict Law Enforcement - Peace FM Online
RAPH Stock | 0.26 0.00 0.00% |
Under 61% of Raphael Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Raphael Pharmaceutical suggests that many traders are alarmed regarding Raphael Pharmaceutical's prospects. Raphael Pharmaceutical's investing sentiment shows overall attitude of investors towards Raphael Pharmaceutical.
Raphael |
Health Experts Raise Alarm Call For Strict Law Enforcement Peace FM Online
Read at news.google.com
Raphael Pharmaceutical Fundamental Analysis
We analyze Raphael Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Raphael Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Raphael Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Raphael Pharmaceutical is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Raphael Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Raphael Pharmaceutical otc stock to make a market-neutral strategy. Peer analysis of Raphael Pharmaceutical could also be used in its relative valuation, which is a method of valuing Raphael Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Raphael Pharmaceutical Related Equities
AMKR | Amkor Technology | 2.42 | ||||
RSVR | Reservoir Media | 1.94 | ||||
PLXS | Plexus Corp | 1.09 | ||||
VLN | Valens | 0.90 | ||||
WB | Weibo Corp | 0.58 | ||||
SONO | Sonos | 0.48 | ||||
KNDI | Kandi Technologies | 2.94 | ||||
PINS | 3.41 |
Complementary Tools for Raphael OTC Stock analysis
When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |